ORLANDO, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced it will release its Third Quarter 2024 financial results after the market closes on Thursday, November 7, 2024. Abacus will hold a conference call to discuss the financial results at 5:00 pm Eastern Time on November 7, 2024. A live webcast of the conference call will be available on Abacus’ inves ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...

Abacus Life, Inc. (ABL) shares ended the last trading session 5.4% higher at $10.40. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.1% loss over the past four weeks.ABL stays focused on consolidating its position as a leading market maker and global alternative asset manager.  The strength of partnerships with carriers and reinsurers remains a key contributor to its performance. Also, along with core business o ...

Shares of Abacus Life, Inc. (ABL) have gained 1.9% over the past four weeks to close the last trading session at $10.40, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14 indicates a potential upside of 34.6%.The mean estimate comprises three short-term price targets with a standard deviation of $2. While the lowest estimate of $12 indicates a 15.4% increase from the current p ...

ORLANDO, Fla., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that its popular Abacus Policy Value Calculator, which recently launched its newest generation, has surpassed 150,000 individual submissions from insureds, totaling more than $87 billion in face value. “Since the original version of the calculator, we have been proud to provide over 150,000 insu ...

ORLANDO, Fla., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that Corey McLaren has joined Abacus as Managing Director, Capital Markets. Based in Boston, Mr. McLaren has almost two decades of experience in financial services, including over fifteen years of business development and management experience directly related to life settlements. Mr. McLaren mo ...

Abacus Life, Inc. (ABL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in ear ...

Shares of Abacus Life, Inc. (ABL) have gained 3.7% over the past four weeks to close the last trading session at $10.30, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.67 indicates a potential upside of 32.7%.The average comprises three short-term price targets ranging from a low of $12 to a high of $15, with a standard deviation of $1.53. While the lowest estimate indicate ...

文章核心观点 - 公司Abacus Life与Lorisco Life建立新的合作伙伴关系,推出基于机器学习和现代蛋白质组学的健康预测平台PREADISAN™ [1][3][4] - PREADISAN™风险评分是一种创新的评估和规划工具,可以生成个性化的洞见,超越传统的基于统计的预期寿命评估 [4] - 该合作关系将为Abacus的客户提供定制的金融产品和服务,进一步增强Abacus在寿命长期和精算技术领域的领先能力 [5][7][8] 公司概况 - Abacus Life是一家领先的全球另类资产管理公司和做市商,专注于使用先进的寿命长期和精算技术来购买消费者寻求流动性的人寿保单,为机构投资者创造一个与市场波动无关的高收益资产类别 [9] - Abacus的寿命长期财富管理服务和投资产品利用公司多年的数据和专有算法,帮助财务顾问为客户创造更加定制化的计划并获得非相关投资基金 [10] - Lorisco Life是一家使用蛋白质组学和预测建模提供可访问、定制的寿命长期和慢性病风险评分的公司,其专有机器学习算法结合传统因素和现代蛋白质组学标记 [11] 行业趋势 - 该合作关系旨在通过蛋白质组学和机器学习为终端用户提供更个性化的健康预测 [6] - 该技术有助于Abacus为客户提供更加定制化的退休规划和风险管理洞见 [8] - 该创新技术有助于推动寿命长期和健康在未来金融规划和人寿结算中的重要性 [7]

财务数据和关键指标变化 - 第二季度总收入同比增长超过一倍至29.1百万美元 [10][11] - 调整后EBITDA同比增长83%至16.7百万美元,调整后EBITDA利润率为57.5% [26] - 调整后净利润同比增长75%至11.8百万美元 [26] - 年化调整后权益回报率和投资资本回报率均为18% [27] 各条业务线数据和关键指标变化 - 政策收购资本部署同比增加75%至104.7百万美元,收购政策数量同比增加95% [22] - 公司持有458份政策,452份采用公允价值法核算,6份采用投资法核算 [23] 各个市场数据和关键指标变化 - 公司与Amcor建立全国性分销关系,将通过Amcor的40多家经纪总代理提供保险和退休解决方案 [17] 公司战略和发展方向及行业竞争 - 公司完成对Carlisle Management Company和FCF Advisors的收购,进一步拓展资产管理业务,实现全球化布局 [13][15] - 公司完成9000万美元的增发,为业务发展提供资金支持 [16] - 公司认为当前市场环境有利于其业务发展,无论是市场波动还是利率变化 [33] 管理层对经营环境和未来前景的评论 - 管理层对公司未来发展前景表示乐观,认为公司有望实现可持续和盈利增长 [19][29] - 管理层表示将继续利用公司的专业优势和大量的寿命数据,拓展新的业务领域 [18][29] 其他重要信息 - 公司将在2024年第三季度或更早时间将增发资金全部部署完毕 [33] - 公司将继续关注并购机会,但重点在于整合现有收购标的 [45][47] - 公司的Abacus Tech业务正在稳步发展,正在拓展新客户 [50]